Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |